CM
Charles Q Morris
Chief Medical Officer

Charles Q Morris insider trades: Radius Health (RDUS) stock sales

Chief Medical Officer, Radius Health Last trade Feb 26, 2020 22 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
11
Open-market trades
since 2011
4
Companies
last trade 2020

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Charles reports to the SEC

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
Feb 26, 2020RDUS↓ Sell$23K
Nov 27, 2015IMGN↓ Sell10b5-1$72K
Nov 28, 2014IMGN↓ Sell$54K
Feb 26, 2014IMGN↓ Sell$120K
Feb 20, 2014IMGN↓ Sell$234K
Jan 22, 2014IMGN↓ Sell$121K
Nov 26, 2013IMGN↓ Sell$172K
Apr 27, 2012ALTH↓ Sell10b5-1$14K
Feb 29, 2012ALTH↓ Sell10b5-1$15K
Nov 15, 2011ALTH↓ Sell10b5-1$26K
Apr 27, 2011ALTH↓ Sell10b5-1$28K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Charles Q Morris's insider trades

Charles Q Morris is Chief Medical Officer at Radius Health (RDUS). Since Apr 27, 2011, Charles has reported no open-market purchases and 11 sales worth $880K on SEC Form 4. There have been no open-market trades in the last 12 months.

5 sales (18% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.

Their filings also include grants and awards (11 filings), option exercises (3 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RDUS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.